🔗 Share this article

Treasury head Reeves has stated she is preparing "specific measures to tackle cost of living issues" in next month's Budget.

During an interview with media outlets, she emphasized that lowering inflation is a collective task of both the government and the Bank of England.

The UK's inflation rate is forecast to be the most elevated among the G7 industrialized countries this year and the following year.

Potential Utility Cost Interventions

Reports indicate the government could intervene to lower utility costs, for example by cutting the present 5% level of VAT applied on energy supplies.

Another option is to reduce some of the regulatory levies currently added to bills.

Fiscal Constraints and Analyst Expectations

The administration will receive the next assessment from the official forecaster, the Office for Budget Responsibility, on Monday, which will clarify how much scope there is for these measures.

The expectation from the majority of analysts is that the Chancellor will have to announce tax rises or budget cuts in order to fulfill her declared fiscal targets.

Previously on the same day, calculations showed there was a £22 billion shortfall for the chancellor to address, which is at the lower end of expectations.

"It is a joint responsibility between the Bank of England and the government to bear down further on some of the causes of price increases," the Chancellor informed reporters in the US capital, at the conferences of the International Monetary Fund and World Bank.

Tax Commitments and International Concerns

While a great deal of the focus has been on likely tax increases, the Treasury chief said the latest figures from the OBR had not altered her commitment to campaign commitments not to raise rates on earnings tax, sales tax or social security contributions.

She attributed an "uncertain global environment" with growing geopolitical and commercial concerns for the Budget revenue measures, probably to be directed on those "wealthiest."

Global Trade Tensions

Commenting on worries about the UK's economic relations with the Asian nation she said: "Our national security always take priority."

Recent announcement by China to strengthen export controls on rare earths and other resources that are key for advanced tech manufacturing led American leader Donald Trump to suggest an additional 100% tariff on imports from China, increasing the risk of an full-scale commercial conflict between the two global powers.

The US Treasury Secretary called China's action "economic coercion" and "a global supply chain control attempt."

Questioned on considering the American proposal to participate in its conflict with the Asian nation, the Chancellor said she was "deeply worried" by China's measures and called on the Beijing authorities "to avoid restrictions and limit trade."

She said the move was "harmful for the global economy and creates additional headwinds."

"I believe there are fields where we should challenge China, but there are also significant prospects to sell into China's economy, including banking sector and other sectors of the economic system. We've got to maintain that balance correct."

The chancellor also confirmed she was cooperating with G7 counterparts "on our own critical minerals approach, so that we are less reliant."

NHS Medicine Pricing and Funding

Reeves also acknowledged that the price the National Health Service pays for pharmaceuticals could rise as a consequence of current discussions with the US government and its drugs companies, in exchange for reduced taxes and investment.

A number of the biggest global drug companies have said lately that they are either delaying or abandoning investments in the UK, with some blaming the modest returns they are receiving.

Last month, the government science advisor said the cost the NHS pays for medicines would must increase to prevent businesses and pharmaceutical investment leaving the United Kingdom.

Reeves stated to media: "It has been observed because of the payment system, that medical research, recent pharmaceuticals have not been offered in the UK in the manner that they are in other EU nations."

"We want to ensure that people receiving treatment from the NHS are able to access the top critical drugs in the globe. And so we are examining these issues, and... looking to attract increased investment into the UK."